BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29589152)

  • 21. Diagnostic Yield of Epilepsy Panels in Children With Medication-Refractory Epilepsy.
    Segal E; Pedro H; Valdez-Gonzalez K; Parisotto S; Gliksman F; Thompson S; Sabri J; Fertig E
    Pediatr Neurol; 2016 Nov; 64():66-71. PubMed ID: 27726903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Future of Next-Generation Sequencing in Neurology.
    LePichon JB; Saunders CJ; Soden SE
    JAMA Neurol; 2015 Sep; 72(9):971-2. PubMed ID: 26148113
    [No Abstract]   [Full Text] [Related]  

  • 23. Exome sequencing in adult neurology practice: Challenges and rewards in a mixed resource setting.
    Nagappa M; Bindu PS; Sinha S; Mathuranath PS; Taly AB
    Clin Neurol Neurosurg; 2018 Nov; 174():48-56. PubMed ID: 30212743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolution of comprehensive genetic analysis in neurology: Implications for precision medicine.
    Papadopoulou E; Pepe G; Konitsiotis S; Chondrogiorgi M; Grigoriadis N; Kimiskidis VK; Tsivgoulis G; Mitsikostas DD; Chroni E; Domouzoglou E; Tsaousis G; Nasioulas G
    J Neurol Sci; 2023 Apr; 447():120609. PubMed ID: 36905813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic testing in neurology.
    Jain V; Irving R; Williams A
    Pract Neurol; 2023 Oct; 23(5):420-429. PubMed ID: 37468300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic yield and recognized barriers of an adult neurogenetics clinic.
    Peleg A; Sagi-Dain L; Golan D
    J Community Genet; 2021 Oct; 12(4):569-576. PubMed ID: 34478057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicoepidemiological analysis of genetic testing in 1,000 cases of hereditary neurological disorders].
    Kametaka S; Ikeda Y; Abe K
    Rinsho Shinkeigaku; 2011 Jul; 51(7):471-7. PubMed ID: 21823505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Simple Practical Guide to Genomic Diagnostics in a Pediatric Setting.
    Taylor A; Alloub Z; Tayoun AA
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic testing in the fetus and child].
    Bartholdi D; Miny P
    Ther Umsch; 2013 Nov; 70(11):621-31. PubMed ID: 24168795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurology Individualized Medicine: When to Use Next-Generation Sequencing Panels.
    Klein CJ; Foroud TM
    Mayo Clin Proc; 2017 Feb; 92(2):292-305. PubMed ID: 28160876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders.
    Mallett AJ; McCarthy HJ; Ho G; Holman K; Farnsworth E; Patel C; Fletcher JT; Mallawaarachchi A; Quinlan C; Bennetts B; Alexander SI
    Kidney Int; 2017 Dec; 92(6):1493-1506. PubMed ID: 28844315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical approach to the patient with neurogenetic disease.
    Bird TD; Smith CO
    Handb Clin Neurol; 2018; 147():3-9. PubMed ID: 29325619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization and diagnostic yield of neurogenetic testing at a tertiary care facility.
    Edlefsen KL; Tait JF; Wener MH; Astion M
    Clin Chem; 2007 Jun; 53(6):1016-22. PubMed ID: 17446330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axons to Exons: the Molecular Diagnosis of Rare Neurological Diseases by Next-Generation Sequencing.
    Warman Chardon J; Beaulieu C; Hartley T; Boycott KM; Dyment DA
    Curr Neurol Neurosci Rep; 2015 Sep; 15(9):64. PubMed ID: 26289954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Yield of an Algorithm for Neonatal and Infantile Cholestasis Integrating Next-Generation Sequencing.
    Nicastro E; Di Giorgio A; Marchetti D; Barboni C; Cereda A; Iascone M; D'Antiga L
    J Pediatr; 2019 Aug; 211():54-62.e4. PubMed ID: 31160058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic testing in neurological diseases.
    Biskup S; Gasser T
    J Neurol; 2012 Jun; 259(6):1249-54. PubMed ID: 22619054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updates in the genetic evaluation of the child with global developmental delay or intellectual disability.
    Flore LA; Milunsky JM
    Semin Pediatr Neurol; 2012 Dec; 19(4):173-80. PubMed ID: 23245550
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.